Dyadic International, Inc.

Common Stock Alternative Reporting
OTCQX U.S. Premier
Verified Company Profile 10/27/2016
Contact Info
  • 140 Intracoastal Pointe Drive
  • Suite 404
  • Jupiter, FL 33477

Business Description

Financial Reporting/Disclosure
Reporting Status Alternative Reporting Standard
Deregistered a/o Jun 04, 2009
Audited Financials Audited
Latest Report Sep 30, 2016 Quarterly Report
CIK 0001213809
Fiscal Year End 12/31
OTC Marketplace OTCQX U.S. Premier
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: DE, USA
Year of Inc. 2004
Employees 9 a/o Sep 30, 2016
Company Officers/Contacts
Mark Emalfarb CEO, President
Thomas L. Dubinski CFO
Ping Rawson Director, Financial Reporting
Hiedi Zosiak Executive Assistant
Company Directors
Michael P. Tarnok Chairman
Mark Emalfarb
Seth Herbst
Jack Kaye
Stephen Warner
Company Notes
  • Formerly=CCP Worldwide, Inc. until 11-04
Service Providers
OTCQX Advisor
Not Available
Accounting/Auditing Firm
Brabo, Carlsen & Cahill
1111 E. Tahquitz Canyon Way
Suite 203
Palm Springs, CA, 92262
United States

Mayer Hoffman McCann, P.C.
1675 N. Military Trail
5th Floor
Boca Raton, FL, 33486
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available
DYAI Security Details
Share Structure
Market Value1 $55,826,204 a/o Dec 09, 2016
Authorized Shares 100,000,000 a/o Sep 30, 2016
Outstanding Shares 34,460,620 a/o Sep 30, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 19,948,098 a/o Sep 30, 2016
Par Value 0.001
Shareholders of Record 50 a/o Sep 30, 2016
Short Selling Data
Short Interest 911 (0%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security